I. C. Benlidayi Et Al. , "Risedronate therapy for neurofibromatosis Type 1-related low bone mass: a stitch in time saves nine," ACTA CLINICA BELGICA , vol.70, no.2, pp.130-132, 2015
Benlidayi, I. C. Et Al. 2015. Risedronate therapy for neurofibromatosis Type 1-related low bone mass: a stitch in time saves nine. ACTA CLINICA BELGICA , vol.70, no.2 , 130-132.
Benlidayi, I. C., ORTAÇ, E. A., & Kozanoglu, E., (2015). Risedronate therapy for neurofibromatosis Type 1-related low bone mass: a stitch in time saves nine. ACTA CLINICA BELGICA , vol.70, no.2, 130-132.
Benlidayi, İLKE, EMİNE AYGÜL ORTAÇ, And MUSTAFA ERKAN KOZANOĞLU. "Risedronate therapy for neurofibromatosis Type 1-related low bone mass: a stitch in time saves nine," ACTA CLINICA BELGICA , vol.70, no.2, 130-132, 2015
Benlidayi, İLKE C. Et Al. "Risedronate therapy for neurofibromatosis Type 1-related low bone mass: a stitch in time saves nine." ACTA CLINICA BELGICA , vol.70, no.2, pp.130-132, 2015
Benlidayi, I. C. ORTAÇ, E. A. And Kozanoglu, E. (2015) . "Risedronate therapy for neurofibromatosis Type 1-related low bone mass: a stitch in time saves nine." ACTA CLINICA BELGICA , vol.70, no.2, pp.130-132.
@article{article, author={İLKE COŞKUN BENLİDAYI Et Al. }, title={Risedronate therapy for neurofibromatosis Type 1-related low bone mass: a stitch in time saves nine}, journal={ACTA CLINICA BELGICA}, year=2015, pages={130-132} }